Study #2019-0953
PISCES I: Precision Implemented Smoking Cessation Evaluation Study
MD Anderson Study Status
Enrolling
Treatment Agent
Varenicline, Nicotine Replacement, Bupropion Hydrochloride Controlled-release
Description
This phase IV trial investigates how to personalize treatments (such as medications and/or counseling) for quitting smoking based on the unique character traits of participants. Nicotine replacement therapy, counseling, and/or drugs such as varenicline and bupropion may help participants quit smoking or change smoking behavior. This trial may also help doctors individualize smoking cessation treatment for participants who do not quit smoking after the first course of treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cigarette Smoking-Related Carcinoma
Study phase:
Phase IV
Physician name:
Paul Cinciripini
Department:
Behavioral Science
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.